Ā | Ā | Bone metastases (nā=ā485) | Ā | Miscellaneous painful tumours (nā=ā302) | ||||
---|---|---|---|---|---|---|---|---|
NRF model cutoff values | Ā | NRF model cutoff values | ||||||
1 | 2 | 3 | Ā | 1 | 2 | 3 | ||
Sensitivity (%) | 2-month | 96 | 74 | 0 | Ā | 87 | 34 | 0 |
Ā | 4-month | 97 | 68 | 0 | Ā | 86 | 32 | 0 |
Ā | 12-month | 92 | 92 | 0 | Ā | 76 | 23 | 0 |
Specificity (%) | 2-month | 23 | 70 | 100 | Ā | 35 | 85 | 100 |
Ā | 4-month | 28 | 78 | 100 | Ā | 39 | 89 | 100 |
Ā | 12-month | 41 | 88 | 100 | Ā | 45 | 94 | 100 |
PPV (%) | 2-month | 19 | 32 | NA | Ā | 14 | 22 | NA |
Ā | 4-month | 36 | 56 | NA | Ā | 30 | 47 | NA |
Ā | 12-month | 70 | 86 | NA | Ā | 62 | 83 | NA |
NPV (%) | 2-month | 97 | 94* | 84 | Ā | 96 | 91* | 89 |
Ā | 4-month | 96 | 85 | 70 | Ā | 90 | 82 | 77 |
Ā | 12-month | 78 | 56 | 41 | Ā | 62 | 51 | 46 |